AstraZeneca Pharma India Limited

NSEI:ASTRAZEN Rapport sur les actions

Capitalisation boursière : ₹187.9b

AstraZeneca Pharma India Gestion

Gestion contrôle des critères 1/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Sanjeev Panchal

Directeur général

₹38.7m

Rémunération totale

Pourcentage du salaire du PDG83.4%
Durée du mandat du directeur général1.8yrs
Propriété du PDGn/a
Durée moyenne d'occupation des postes de direction1.3yrs
Durée moyenne du mandat des membres du conseil d'administrationless than a year

Mises à jour récentes de la gestion

Recent updates

AstraZeneca Pharma India Limited's (NSE:ASTRAZEN) Earnings Haven't Escaped The Attention Of Investors

Sep 18
AstraZeneca Pharma India Limited's (NSE:ASTRAZEN) Earnings Haven't Escaped The Attention Of Investors

We Believe AstraZeneca Pharma India's (NSE:ASTRAZEN) Earnings Are A Poor Guide For Its Profitability

Jun 03
We Believe AstraZeneca Pharma India's (NSE:ASTRAZEN) Earnings Are A Poor Guide For Its Profitability

Why Investors Shouldn't Be Surprised By AstraZeneca Pharma India Limited's (NSE:ASTRAZEN) P/S

May 22
Why Investors Shouldn't Be Surprised By AstraZeneca Pharma India Limited's (NSE:ASTRAZEN) P/S

We Ran A Stock Scan For Earnings Growth And AstraZeneca Pharma India (NSE:ASTRAZEN) Passed With Ease

Apr 04
We Ran A Stock Scan For Earnings Growth And AstraZeneca Pharma India (NSE:ASTRAZEN) Passed With Ease

Is Now The Time To Put AstraZeneca Pharma India (NSE:ASTRAZEN) On Your Watchlist?

Nov 10
Is Now The Time To Put AstraZeneca Pharma India (NSE:ASTRAZEN) On Your Watchlist?

AstraZeneca Pharma India's (NSE:ASTRAZEN) Dividend Will Be Increased To ₹16.00

Jul 06
AstraZeneca Pharma India's (NSE:ASTRAZEN) Dividend Will Be Increased To ₹16.00

Is Now The Time To Put AstraZeneca Pharma India (NSE:ASTRAZEN) On Your Watchlist?

Jun 16
Is Now The Time To Put AstraZeneca Pharma India (NSE:ASTRAZEN) On Your Watchlist?

Increases to CEO Compensation Might Be Put On Hold For Now at AstraZeneca Pharma India Limited (NSE:ASTRAZEN)

Aug 02
Increases to CEO Compensation Might Be Put On Hold For Now at AstraZeneca Pharma India Limited (NSE:ASTRAZEN)

Here's Why I Think AstraZeneca Pharma India (NSE:ASTRAZEN) Is An Interesting Stock

Feb 25
Here's Why I Think AstraZeneca Pharma India (NSE:ASTRAZEN) Is An Interesting Stock

Could The AstraZeneca Pharma India Limited (NSE:ASTRAZEN) Ownership Structure Tell Us Something Useful?

Feb 04
Could The AstraZeneca Pharma India Limited (NSE:ASTRAZEN) Ownership Structure Tell Us Something Useful?

Declining Stock and Solid Fundamentals: Is The Market Wrong About AstraZeneca Pharma India Limited (NSE:ASTRAZEN)?

Jan 18
Declining Stock and Solid Fundamentals: Is The Market Wrong About AstraZeneca Pharma India Limited (NSE:ASTRAZEN)?

Announcing: AstraZeneca Pharma India (NSE:ASTRAZEN) Stock Increased An Energizing 282% In The Last Five Years

Dec 31
Announcing: AstraZeneca Pharma India (NSE:ASTRAZEN) Stock Increased An Energizing 282% In The Last Five Years

We're Not Counting On AstraZeneca Pharma India (NSE:ASTRAZEN) To Sustain Its Statutory Profitability

Dec 13
We're Not Counting On AstraZeneca Pharma India (NSE:ASTRAZEN) To Sustain Its Statutory Profitability

Here's Why We Think AstraZeneca Pharma India (NSE:ASTRAZEN) Is Well Worth Watching

Nov 25
Here's Why We Think AstraZeneca Pharma India (NSE:ASTRAZEN) Is Well Worth Watching

Here's What We Think About AstraZeneca Pharma India's (NSE:ASTRAZEN) CEO Pay

Nov 07
Here's What We Think About AstraZeneca Pharma India's (NSE:ASTRAZEN) CEO Pay

What Kind Of Investors Own Most Of AstraZeneca Pharma India Limited (NSE:ASTRAZEN)?

Oct 20
What Kind Of Investors Own Most Of AstraZeneca Pharma India Limited (NSE:ASTRAZEN)?

AstraZeneca Pharma India Limited's (NSE:ASTRAZEN) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Sep 24
AstraZeneca Pharma India Limited's (NSE:ASTRAZEN) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

If You Had Bought AstraZeneca Pharma India (NSE:ASTRAZEN) Stock Three Years Ago, You Could Pocket A 298% Gain Today

Aug 28
If You Had Bought AstraZeneca Pharma India (NSE:ASTRAZEN) Stock Three Years Ago, You Could Pocket A 298% Gain Today

What Did AstraZeneca Pharma India's (NSE:ASTRAZEN) CEO Take Home Last Year?

Aug 02
What Did AstraZeneca Pharma India's (NSE:ASTRAZEN) CEO Take Home Last Year?

Could The AstraZeneca Pharma India Limited (NSE:ASTRAZEN) Ownership Structure Tell Us Something Useful?

Jul 12
Could The AstraZeneca Pharma India Limited (NSE:ASTRAZEN) Ownership Structure Tell Us Something Useful?

Analyse de la rémunération des PDG

Comment la rémunération de Sanjeev Panchal a-t-elle évolué par rapport aux bénéfices de AstraZeneca Pharma India?
DateRémunération totaleSalaireBénéfices de l'entreprise
Jun 30 2024n/an/a

₹959m

Mar 31 2024₹39m₹32m

₹2b

Dec 31 2023n/an/a

₹1b

Sep 30 2023n/an/a

₹2b

Jun 30 2023n/an/a

₹1b

Mar 31 2023₹21m₹5m

₹993m

Rémunération vs marché: La rémunération totale de Sanjeev ($USD 459.01K ) est dans la moyenne des entreprises de taille similaire sur le marché Indian ($USD 489.30K ).

Rémunération et revenus: La rémunération de Sanjeev a augmenté de plus de 20 % tandis que les bénéfices de l'entreprise ont chuté de plus de 20 % au cours de l'année écoulée.


PDG

Sanjeev Panchal (47 yo)

1.8yrs

Titularisation

₹38,725,314

Compensation

Dr. Sanjeev Kumar Panchal serves as Country President of AstraZeneca Pharma India Limited since January 01, 2023 and serves as its Managing Director since January 01, 2023. He serves as Director of AstraZe...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Sanjeev Panchal
MD, Country President & Director1.8yrs₹38.73mpas de données
Bhavana Agrawal
Whole-Time Director & CFO1.1yrs₹30.59mpas de données
Pratap Bhuvanagiri
Legal Counsel7.8yrs₹3.73mpas de données
Manasa R.
Company Secretary & Compliance Officer2.3yrspas de donnéespas de données
Smita Saha
Vice President of Human Resourcesno data₹12.28mpas de données
Ayush Agarwal
Interim Business Unit Head of Oncology & Director of Commercial Excellence1.3yrspas de donnéespas de données
Praveen Akkinepally
Head of Oncology Business Unitless than a yearpas de donnéespas de données
Vinay Sharma
Business Unit Head - Rare Disease unitless than a yearpas de donnéespas de données
Pankaj Jain
Legal Headno datapas de donnéespas de données

1.3yrs

Durée moyenne de l'emploi

Gestion expérimentée: L'équipe de direction de ASTRAZEN n'est pas considérée comme expérimentée (ancienneté moyenne 1.3 ans), ce qui suggère une nouvelle équipe.


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Sanjeev Panchal
MD, Country President & Director1.8yrs₹38.73mpas de données
Bhavana Agrawal
Whole-Time Director & CFOless than a year₹30.59mpas de données
Revathy Ashok
Independent Non-Executive Director7.9yrs₹1.20mpas de données
Monica Widhani
Additional Independent Directorless than a yearpas de donnéespas de données
Hooi Chuah
Additional Non-Executive Directorless than a yearpas de donnéespas de données
Nirula Shilpa Divekar
Independent Non-Executive Chairperson of the Board2.9yrs₹1.30mpas de données
Sylvia Lorena Ramon
Non-Executive Directorless than a yearpas de donnéespas de données

1.0yrs

Durée moyenne de l'emploi

58yo

Âge moyen

Conseil d'administration expérimenté: Le conseil d'administration de la ASTRAZEN n'est pas considéré comme expérimenté ( 1 années d'ancienneté moyenne), ce qui suggère un nouveau conseil d'administration.